• OPEN AN ACCOUNT
Indian Indices
Sensex
81,047.35 47.95
( 0.06%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
58,738.13 1,303.36
(2.27%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Reliance Industries Ltd
Industry :  Refineries
BSE Code
ISIN Demat
Book Value()
500325
INE002A01018
433.7077533
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RELIANCE
39.4
1790354.38
EPS(TTM)
Face Value()
Div & Yield %
33.58
10
0.45
 

Godavari Drugs standalone net profit rises 44.94% in the March 2026 quarter
May 28,2026
Net profit of Godavari Drugs rose 44.94% to Rs 1.29 crore in the quarter ended March 2026 as against Rs 0.89 crore during the previous quarter ended March 2025. Sales rose 30.04% to Rs 33.16 crore in the quarter ended March 2026 as against Rs 25.50 crore during the previous quarter ended March 2025.

For the full year,net profit declined 6.62% to Rs 4.09 crore in the year ended March 2026 as against Rs 4.38 crore during the previous year ended March 2025. Sales declined 6.65% to Rs 105.81 crore in the year ended March 2026 as against Rs 113.35 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales33.1625.50 30 105.81113.35 -7
OPM %8.8712.20 -9.7410.44 -
PBDT2.132.11 1 7.138.08 -12
PBT1.521.44 6 4.705.63 -17
NP1.290.89 45 4.094.38 -7